Axogen (AXGN)
Axogen on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as electromedical & electrotherapeutic apparatus.
4.7M
Short interest
settlement 2026-09-30
4.2
Days to cover
+1.3 days vs prior
64.7%
Short share of volume
2026-10-09
94,989
Fails to deliver
settlement 2026-08-27
Wed 28 Oct
Next earnings
estimated date
-$4.7M
Insider flow, 90 days
0 buys, 4 sells
As of 2026-10-09.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in AXGN is 4,697,283 shares, up 887,933 shares over the last month. Over the last 48 readings it ranged from 1,014,406 shares (13 December 2024) to 5,443,801 shares (15 July 2026). At the reported average volume of 1.1M shares a day that is 4.2 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/axgn" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 4,697,283 | +15.8% | 1,127,117 | 4.17 |
| 2026-09-15 | 4,055,417 | +6.5% | 1,418,348 | 2.86 |
| 2026-08-31 | 3,809,350 | +13.2% | 903,167 | 4.22 |
| 2026-08-14 | 3,365,313 | -17.4% | 826,554 | 4.07 |
| 2026-07-31 | 4,071,593 | -25.2% | 1,217,149 | 3.35 |
| 2026-07-15 | 5,443,801 | +17.4% | 1,495,870 | 3.64 |
| 2026-06-30 | 4,634,995 | +26.5% | 1,628,697 | 2.85 |
| 2026-06-15 | 3,663,617 | +8.7% | 1,218,478 | 3.01 |
| 2026-05-29 | 3,369,844 | +5.2% | 811,549 | 4.15 |
| 2026-05-15 | 3,202,431 | -5.9% | 786,698 | 4.07 |
| 2026-04-30 | 3,402,909 | -8.8% | 1,577,193 | 2.16 |
| 2026-04-15 | 3,729,624 | +6.6% | 915,868 | 4.07 |
| 2026-03-31 | 3,498,529 | +14.3% | 932,226 | 3.75 |
| 2026-03-13 | 3,059,405 | +5.7% | 830,405 | 3.68 |
| 2026-02-27 | 2,894,327 | +6.0% | 980,234 | 2.95 |
| 2026-02-13 | 2,729,549 | -0.8% | 845,081 | 3.23 |
| 2026-01-30 | 2,752,471 | -3.5% | 1,216,060 | 2.26 |
| 2026-01-15 | 2,852,855 | +6.2% | 850,751 | 3.35 |
| 2025-12-31 | 2,685,334 | +14.6% | 710,533 | 3.78 |
| 2025-12-15 | 2,342,837 | -17.8% | 1,072,166 | 2.19 |
| 2025-11-28 | 2,849,251 | +8.9% | 882,686 | 3.23 |
| 2025-11-14 | 2,616,565 | -4.3% | 701,889 | 3.73 |
| 2025-10-31 | 2,733,034 | +10.1% | 983,712 | 2.78 |
| 2025-10-15 | 2,482,395 | +17.6% | 883,126 | 2.81 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of AXGN volume is 64.7%, up 8.2 points over the last five sessions. Over the last 30 readings it ranged from 50.1% (31 August 2026) to 86.4% (8 September 2026). The latest reading is in line with the 30-session average of 66.2%, on 328K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 212K | 328K | 64.7% | 0 |
| 2026-10-08 | 378K | 478K | 79.1% | 2,649 |
| 2026-10-07 | 349K | 563K | 62.0% | 14,186 |
| 2026-10-06 | 544K | 962K | 56.6% | 22 |
| 2026-10-05 | 503K | 739K | 68.1% | 10 |
| 2026-10-02 | 678K | 1.2M | 56.5% | 0 |
| 2026-10-01 | 337K | 461K | 73.0% | 0 |
| 2026-09-30 | 231K | 364K | 63.4% | 0 |
| 2026-09-29 | 243K | 419K | 58.0% | 0 |
| 2026-09-28 | 139K | 199K | 69.8% | 0 |
| 2026-09-25 | 181K | 250K | 72.6% | 0 |
| 2026-09-24 | 232K | 306K | 75.8% | 0 |
| 2026-09-23 | 310K | 396K | 78.2% | 0 |
| 2026-09-22 | 289K | 485K | 59.6% | 0 |
| 2026-09-21 | 316K | 459K | 68.8% | 300 |
| 2026-09-18 | 254K | 334K | 76.1% | 7 |
| 2026-09-17 | 209K | 302K | 69.3% | 0 |
| 2026-09-16 | 338K | 546K | 62.0% | 4,000 |
| 2026-09-15 | 489K | 631K | 77.5% | 750 |
| 2026-09-14 | 435K | 818K | 53.1% | 400 |
| 2026-09-11 | 1.2M | 1.9M | 64.1% | 14,925 |
| 2026-09-10 | 1.2M | 2.1M | 57.0% | 20,368 |
| 2026-09-09 | 166K | 199K | 83.4% | 0 |
| 2026-09-08 | 186K | 215K | 86.4% | 12,262 |
| 2026-09-04 | 144K | 217K | 66.3% | 0 |
| 2026-09-03 | 182K | 333K | 54.6% | 0 |
| 2026-09-02 | 189K | 275K | 68.8% | 16 |
| 2026-09-01 | 130K | 250K | 52.0% | 11,812 |
| 2026-08-31 | 166K | 330K | 50.1% | 800 |
| 2026-08-28 | 163K | 279K | 58.6% | 102 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 27 August 2026, the fails-to-deliver balance in AXGN is 94,989 shares, up 94,987 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (17 August 2026) to 94,989 shares (27 August 2026). The latest reading sits at the top of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-27 | 94,989 | $51.58 | $4.9M |
| 2026-08-19 | 2 | $50.19 | $100 |
| 2026-08-18 | 34 | $49.15 | $2K |
| 2026-08-17 | 2 | $48.73 | $97 |
| 2026-08-06 | 803 | $45.22 | $36K |
| 2026-07-30 | 20,276 | $41.37 | $839K |
| 2026-07-28 | 17 | $41.14 | $699 |
| 2026-07-27 | 2,440 | $39.49 | $96K |
| 2026-07-24 | 200 | $39.73 | $8K |
| 2026-07-23 | 200 | $39.37 | $8K |
| 2026-07-22 | 200 | $40.26 | $8K |
| 2026-07-20 | 208 | $39.85 | $8K |
| 2026-07-17 | 56 | $39.78 | $2K |
| 2026-07-13 | 598 | $40.58 | $24K |
| 2026-07-01 | 24 | $46.19 | $1K |
| 2026-06-30 | 393 | $44.72 | $18K |
| 2026-06-29 | 69 | $44.93 | $3K |
| 2026-06-26 | 43 | $44.49 | $2K |
| 2026-06-15 | 25,268 | $43.00 | $1.1M |
| 2026-05-22 | 105 | $41.31 | $4K |
| 2026-05-18 | 799 | $40.99 | $33K |
| 2026-05-07 | 2,551 | $43.48 | $111K |
| 2026-03-30 | 14,988 | $31.28 | $469K |
| 2026-03-27 | 3,161 | $32.25 | $102K |
| 2026-03-19 | 3,405 | $30.94 | $105K |
| 2026-03-18 | 3,340 | $32.75 | $109K |
| 2026-02-26 | 1,305 | $31.22 | $41K |
| 2026-02-23 | 300 | $35.30 | $11K |
| 2026-02-12 | 484 | $33.90 | $16K |
| 2026-02-10 | 34 | $33.93 | $1K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at AXGN reported 4 open-market sells worth $4.7M in the last 90 days and no open-market buys. Latest filing: TYNDALL JOSEPH A. (Director) on 2026-09-02.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | TYNDALL JOSEPH A. | Director | Sell | 4K | $49.70 | $174K | 11K |
| 2026-08-11 | Wendell Amy McBride | Director | Sell | 13K | $48.42 | $647K | 108K |
| 2026-08-11 | Wendell Amy McBride | Director | Option exercise | 13K | $14.85 | $198K | 121K |
| 2026-08-10 | Began Marc A | EVP & General Counsel | Sell | 68K | $47.34 | $3.2M | 50K |
| 2026-08-10 | Began Marc A | EVP & General Counsel | Option exercise | 68K | $8.16 | $551K | 118K |
| 2026-08-07 | Weiler Kathy Johnson | Director | Sell | 14K | $45.30 | $641K | 0 |
| 2026-06-19 | JOHNSON JOHN | Director | Option exercise | 14K | $0.00 | $0 | 14K |
| 2026-06-19 | Wendell Amy McBride | Director | Option exercise | 14K | $0.00 | $0 | 108K |
| 2026-06-19 | Levine Alan M | Director | Option exercise | 14K | $0.00 | $0 | 51K |
| 2026-06-19 | Weiler Kathy Johnson | Director | Option exercise | 14K | $0.00 | $0 | 14K |
| 2026-06-19 | THOMAS PAUL | Director | Option exercise | 19K | $0.00 | $0 | 32K |
| 2026-06-19 | TYNDALL JOSEPH A. | Director | Option exercise | 14K | $0.00 | $0 | 14K |
| 2026-06-19 | Burke William P. Mr. | Director | Option exercise | 14K | $0.00 | $0 | 14K |
| 2026-05-08 | Wendell Amy McBride | Director | Sell | 2K | $42.60 | $70K | 94K |
| 2026-05-08 | Wendell Amy McBride | Director | Option exercise | 2K | $14.85 | $24K | 95K |
| 2026-05-07 | JOHNSON JOHN | Director | Sell | 11K | $43.26 | $478K | 0 |
| 2026-05-07 | JOHNSON JOHN | Director | Option exercise | 11K | $7.04 | $78K | 11K |
| 2026-05-07 | Weiler Kathy Johnson | Director | Sell | 16K | $44.09 | $721K | 0 |
| 2026-05-07 | Weiler Kathy Johnson | Director | Option exercise | 16K | $6.95 | $114K | 16K |
| 2026-05-07 | Kemp Jens | Chief Marketing Officer | Sell | 4K | $43.44 | $174K | 72K |
| 2026-05-07 | Hartley Lindsey Marie | CFO | Sell | 573 | $43.67 | $25K | 65K |
| 2026-05-07 | Hartley Lindsey Marie | CFO | Option exercise | 3K | $8.27 | $25K | 66K |
| 2026-05-07 | Hartley Lindsey Marie | CFO | Sell | 478 | $43.67 | $21K | 63K |
| 2026-05-07 | Hartley Lindsey Marie | CFO | Option exercise | 3K | $8.20 | $21K | 63K |
| 2026-05-07 | Quackenbush Doris | Sales VP | Sell | 4K | $43.51 | $169K | 92K |
| 2026-03-16 | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 5K | $32.84 | $171K | 263K |
| 2026-03-16 | DeVinney Erick Wayne | Chief Innovation Officer | Option exercise | 12K | $0.00 | $0 | 268K |
| 2026-03-16 | DeVinney Erick Wayne | Chief Innovation Officer | Tax withholding | 3K | $32.84 | $94K | 256K |
| 2026-03-16 | DeVinney Erick Wayne | Chief Innovation Officer | Option exercise | 6K | $0.00 | $0 | 259K |
| 2026-03-16 | Hartley Lindsey Marie | CFO | Tax withholding | 2K | $32.84 | $65K | 61K |
| 2026-03-16 | Hartley Lindsey Marie | CFO | Option exercise | 5K | $0.00 | $0 | 63K |
| 2026-03-16 | Hartley Lindsey Marie | CFO | Tax withholding | 2K | $32.84 | $52K | 58K |
| 2026-03-16 | Hartley Lindsey Marie | CFO | Option exercise | 4K | $0.00 | $0 | 59K |
| 2026-03-01 | Kemp Jens | Chief Marketing Officer | Tax withholding | 3K | $30.65 | $90K | 76K |
| 2026-03-01 | DeVinney Erick Wayne | Chief Innovation Officer | Tax withholding | 11K | $30.65 | $346K | 253K |
| 2026-03-01 | Began Marc A | EVP & General Counsel | Tax withholding | 4K | $30.65 | $136K | 50K |
| 2026-03-01 | Began Marc A | EVP & General Counsel | Option exercise | 11K | $0.00 | $0 | 55K |
| 2026-02-26 | Hartley Lindsey Marie | CFO | Tax withholding | 7K | $31.90 | $211K | 55K |
| 2026-02-26 | Hartley Lindsey Marie | CFO | Grant | 17K | $0.00 | $0 | 62K |
| 2026-02-26 | Kemp Jens | Chief Marketing Officer | Tax withholding | 15K | $31.90 | $492K | 79K |
| 2026-02-26 | Kemp Jens | Chief Marketing Officer | Grant | 51K | $0.00 | $0 | 95K |
| 2026-02-26 | DeVinney Erick Wayne | Chief Innovation Officer | Tax withholding | 11K | $31.90 | $341K | 264K |
| 2026-02-26 | DeVinney Erick Wayne | Chief Innovation Officer | Grant | 34K | $0.00 | $0 | 275K |
| 2026-02-26 | Began Marc A | EVP & General Counsel | Tax withholding | 9K | $31.90 | $279K | 43K |
| 2026-02-26 | Began Marc A | EVP & General Counsel | Grant | 34K | $0.00 | $0 | 52K |
| 2026-02-22 | Hartley Lindsey Marie | CFO | Tax withholding | 7K | $35.38 | $237K | 44K |
| 2026-02-22 | Hartley Lindsey Marie | CFO | Grant | 18K | $0.00 | $0 | 51K |
| 2025-12-16 | Wendell Amy McBride | Director | Sell | 18K | $29.31 | $535K | 94K |
| 2025-12-16 | Wendell Amy McBride | Director | Sell | 20K | $29.31 | $599K | 112K |
| 2025-12-16 | Wendell Amy McBride | Director | Sell | 5K | $29.31 | $147K | 133K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON31 Form 144 notices on file for AXGN worth $16.4M at the prices reported; 4 in the last 90 days worth $4.6M. Latest: JOSEPH A TYNDALL filed on 2026-09-02 to sell 3,500 shares ($175K) from 2026-09-02.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-02 | JOSEPH A TYNDALLDirector | 4K | $175K | 0.007% | 2026-09-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-11 | AMY MCBRIDE-WENDELLDirector | 13K | $644K | 0.025% | 2026-08-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-10 | MARC BEGANOfficer | 68K | $3.1M | 0.126% | 2026-08-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-07 | KATHY WEILERDirector | 14K | $628K | 0.026% | 2026-08-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-08 | AMY MCBRIDE-WENDELLDirector | 2K | $70K | 0.003% | 2026-05-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-07 | JOHN H JOHNSONDirector | 11K | $478K | 0.021% | 2026-05-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-07 | DORIS QUACKENBUSHVice President of Sales | 4K | $169K | 0.007% | 2026-05-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-07 | JENS KEMPOfficer | 4K | $174K | 0.008% | 2026-05-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-07 | KATHY WEILERDirector | 16K | $721K | 0.031% | 2026-05-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-16 | Amy McBride-WendellDirector | 44K | $1.3M | 0.095% | 2025-12-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-16 | KATHY WEILERDirector | 47K | $1.4M | 0.101% | 2025-12-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-15 | LINDSEY MARIE HARTLEYOfficer | 15K | $442K | 0.032% | 2025-12-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-11 | MARC BEGANOfficer | 13K | $397K | 0.029% | 2025-12-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-10 | MICHAEL DALEOfficer | 25K | $750K | 0.054% | 2025-12-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-09 | PAUL THOMASDirector | 21K | $634K | 0.046% | 2025-12-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-09 | JOSEPH A TYNDALLDirector | 25K | $778K | 0.054% | 2025-12-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-09 | JOHN H JOHNSONDirector | 22K | $650K | 0.047% | 2025-12-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-08 | JOHN H JOHNSONDirector | 24K | $740K | 0.051% | 2025-12-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-08 | LINDSEY MARIE HARTLEYOfficer | 14K | $454K | 0.031% | 2025-12-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-12 | WILLIAM BURKEDirector | 4K | $86K | 0.008% | 2025-11-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-10 | WILLIAM BURKEDirector | 19K | $453K | 0.042% | 2025-11-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-06 | WILLIAM BURKEDirector | 5K | $125K | 0.012% | 2025-11-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-05 | WILLIAM BURKEDirector | 11K | $272K | 0.025% | 2025-11-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-30 | WILLIAM BURKEDirector | 18K | $406K | 0.040% | 2025-10-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-29 | WILLIAM BURKEDirector | 36K | $654K | 0.079% | 2025-10-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-22 | Burke William P. Mr.Director | 1K | $26K | 0.003% | 2025-10-22 | Fidelity Brokerage Services LLC |
| 2025-10-06 | Burke William P. Mr.Director | 736 | $13K | 0.002% | 2025-10-06 | Fidelity Brokerage Services LLC |
| 2025-10-03 | Burke William P. Mr.Director | 11K | $206K | 0.025% | 2025-10-03 | Fidelity Brokerage Services LLC |
| 2025-10-03 | WILLIAM BURKEDirector | 15K | $267K | 0.032% | 2025-10-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-02 | Burke William P. Mr.Director | 2K | $43K | 0.005% | 2025-10-02 | Fidelity Brokerage Services LLC |
| 2025-10-02 | WILLIAM BURKEDirector | 8K | $136K | 0.017% | 2025-10-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON7 holders report 5% or more of AXGN in their latest filing, all on Schedule 13G (passive). The largest reported stake is Mathew P. Arens at 7.6% of the class (4,072,910 shares), filed 2026-08-14 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-02 | 13G | William Zolezziparent holding company, individual | 4.0M | 6.8% | 2026-10-02 |
| 2026-10-02 | 13G | Divisadero Street Capital, LLCparent holding company, other entity | 4.0M | 6.8% | 2026-10-02 |
| 2026-10-02 | 13G | Divisadero Street Capital Management, LPinvestment adviser, partnership | 4.0M | 6.8% | 2026-10-02 |
| 2026-10-02 | 13G | Divisadero Street Partners GP, LLCother entity | 3.4M | 5.9% | 2026-10-02 |
| 2026-10-02 | 13G | Divisadero Street Partners, L.P.partnership | 3.4M | 5.9% | 2026-10-02 |
| 2026-08-14 | 13G/Ano. 4 | Mathew P. Arensindividual | 4.1M | 7.6% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 4 | First Light Asset Management, LLCinvestment adviser | 3.7M | 7.0% | 2026-06-30 |
| 2026-07-31 | 13G/Ano. 1 | Vanguard Capital Managementinvestment adviser | 2.7M | 5.0% | 2026-06-30 |
| 2026-03-26 | 13G/Ano. 1 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding AXGN at their latest 13F. JSON6 of the 30 tracked managers held AXGN at their latest 13F, $103.0M in total at quarter-end prices. Citadel Advisors is the largest at $62.9M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 1.4M | $62.9M | 0.01% | +1.1M |
| Two Sigma Investments | 2026-06-30 | 319K | $14.7M | 0.01% | -363K |
| D. E. Shaw & Co. | 2026-06-30 | 278K | $12.8M | 0.01% | +13K |
| Point72 Asset Management | 2026-06-30 | 225K | $10.4M | 0.01% | +22K |
| Millennium Management | 2026-06-30 | 27K | $1.3M | 0.00% | -760K |
| AQR Capital Management | 2026-06-30 | 21K | $980K | 0.00% | +10K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Axogen reported revenue of $69.7M, up 23.1% from the same quarter a year earlier, and net loss of $1.5M (-0.03 diluted EPS). In FY 2025 it generated $812K of operating cash flow. As of 2026-06-30, cash was $94.6M against $0 of debt.
- Cash
- $94.6M
- Debt
- $0
- Equity
- $256.3M
- Total assets
- $304.9M
- Shares outstanding
- 53,761,513
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $69.7M | -$1.5M | -2.2% | -0.03 |
| Q1 FY 2026 | 2026-03-31 | $61.5M | -$19.6M | -31.9% | -0.38 |
| Q4 FY 2025derived | 2025-12-31 | $59.9M | -$13.2M | -22.0% | n/a |
| Q3 FY 2025 | 2025-09-30 | $60.1M | $708K | 1.2% | 0.01 |
| Q2 FY 2025 | 2025-06-30 | $56.7M | $579K | 1.0% | 0.01 |
| Q1 FY 2025 | 2025-03-31 | $48.6M | -$3.8M | -7.9% | -0.08 |
| Q4 FY 2024derived | 2024-12-31 | $49.4M | $450K | 0.9% | n/a |
| Q3 FY 2024 | 2024-09-30 | $48.6M | -$1.9M | -3.8% | -0.04 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $225.2M | -$15.7M | $812K | $3.7M | n/a | n/a |
| FY 2024 | 2024-12-31 | $187.3M | -$10.0M | $4.5M | $3.1M | n/a | n/a |
| FY 2023 | 2023-12-31 | $159.0M | -$21.7M | -$5.7M | $13.9M | n/a | n/a |
| FY 2022 | 2022-12-31 | $138.6M | -$28.9M | -$16.1M | $20.1M | n/a | n/a |
| FY 2021 | 2021-12-31 | $127.4M | -$27.0M | -$13.4M | $27.8M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-27 from the cover page.
What this page is
Axogen in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Axogen (AXGN), SEC CIK 805928, listed on Nasdaq, classified by the SEC as electromedical & electrotherapeutic apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-08-27.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-02.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-02.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-29.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-02.JSON and CSV
- Company record
- EDGAR filing index for CIK 805928Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as electromedical & electrotherapeutic apparatus
Other company pages
Datasets
Frequently Asked Questions
How much of AXGN is sold short?
What is AXGN's daily short volume?
Does AXGN have fails to deliver?
Are AXGN insiders buying or selling?
Have AXGN insiders filed to sell?
Who owns 5% or more of AXGN?
What did AXGN report last quarter?
Which tracked 13F managers own AXGN?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.